Skip to main content
Erschienen in: Abdominal Radiology 7/2015

01.10.2015

The shading sign: is it exclusive of endometriomas?

verfasst von: João Lopes Dias, Filipe Veloso Gomes, Rita Lucas, Teresa Margarida Cunha

Erschienen in: Abdominal Radiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate if the shading sign is an exclusive MRI feature of endometriomas or endometrioid tumors, and to analyze its different patterns.

Methods

Three hundred and fourty six women with adnexal masses who underwent 1.5/3-T MRI were included in this retrospective, board-approved study. The shading sign was found in 56 patients, but five cases were excluded due to lack of imaging follow-up or histological correlation. The final sample included 51 women. The type of tumor and the pattern of shading were recorded for each case.

Results

Thirty endometriomas and five endometrioid carcinomas were found. The remaining 16 cases corresponded to other benign and malignant tumors. The overall sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 93%, 59%, and 96%, respectively. Restricting the analysis to cystic lesions without solid or fat component, sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 96%, 94%, and 80%. Five shading patterns were identified: layering (15.7%), liquid–liquid level (11.8%), homogenous (45.1%), heterogeneous (11.8%), and focal/multifocal shading within a complex mass (19.6%). No significant correlation was found between these patterns and the type of tumor.

Conclusions

The shading sign is not exclusive of endometriomas or endometrioid tumors. Homogenous shading was the most prevalent pattern in endometriomas and half of the cases with focal/multifocal shading within a complex mass were endometrioid carcinomas.
Literatur
2.
Zurück zum Zitat Siegelman ES, Outwater EK (1999) Tissue characterization in the female pelvis by means of MR imaging. Radiology 212(1):5–18CrossRefPubMed Siegelman ES, Outwater EK (1999) Tissue characterization in the female pelvis by means of MR imaging. Radiology 212(1):5–18CrossRefPubMed
3.
Zurück zum Zitat Gomori JM, Grossman RI, Hackney DB, et al. (1987) Variable appearances of subacute intracranial hematomas on high-field spin-echo MR. AJNR 8:1019–1026 Gomori JM, Grossman RI, Hackney DB, et al. (1987) Variable appearances of subacute intracranial hematomas on high-field spin-echo MR. AJNR 8:1019–1026
4.
Zurück zum Zitat Nishimura K, Togashi K, Itoh K, et al. (1987) Endometrial cysts of the ovary: MR imaging. Radiology 162(2):315–318CrossRefPubMed Nishimura K, Togashi K, Itoh K, et al. (1987) Endometrial cysts of the ovary: MR imaging. Radiology 162(2):315–318CrossRefPubMed
5.
Zurück zum Zitat Togashi K, Nishimura K, Kimura I, et al. (1991) Endometrial cysts: diagnosis with MR imaging. Radiology 180(1):73–78CrossRefPubMed Togashi K, Nishimura K, Kimura I, et al. (1991) Endometrial cysts: diagnosis with MR imaging. Radiology 180(1):73–78CrossRefPubMed
6.
Zurück zum Zitat Outwater E, Schiebler ML, Owen RS, Schnall MD (1993) Characterization of hemorrhagic adnexal lesions with MR imaging: blinded reader study. Radiology 186(2):489–494CrossRefPubMed Outwater E, Schiebler ML, Owen RS, Schnall MD (1993) Characterization of hemorrhagic adnexal lesions with MR imaging: blinded reader study. Radiology 186(2):489–494CrossRefPubMed
7.
Zurück zum Zitat Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP (2014) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology 271(1):126–132CrossRefPubMed Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP (2014) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology 271(1):126–132CrossRefPubMed
8.
Zurück zum Zitat Scarfone G, Bergamini A, Noli S, et al. (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133:480–484CrossRefPubMed Scarfone G, Bergamini A, Noli S, et al. (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133:480–484CrossRefPubMed
9.
Zurück zum Zitat Tanaka YO, Yoshizako T, Nishida M, et al. (2000) Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR 175:1423–1430CrossRefPubMed Tanaka YO, Yoshizako T, Nishida M, et al. (2000) Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR 175:1423–1430CrossRefPubMed
11.
Zurück zum Zitat Terada T (2012) Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis. Int J Clin Exp Pathol 5(9):924–927PubMedCentralPubMed Terada T (2012) Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis. Int J Clin Exp Pathol 5(9):924–927PubMedCentralPubMed
12.
Zurück zum Zitat Kurman RJ (2014) WHO Classification of Tumours of Female Reproductive Organs, vol. 6, 4th edn. Lyon: IARC Kurman RJ (2014) WHO Classification of Tumours of Female Reproductive Organs, vol. 6, 4th edn. Lyon: IARC
13.
Zurück zum Zitat Prat J (2012) New insights into ovarian cancer pathology. Ann Oncol 23(Supplement 10):x111–x117CrossRefPubMed Prat J (2012) New insights into ovarian cancer pathology. Ann Oncol 23(Supplement 10):x111–x117CrossRefPubMed
Metadaten
Titel
The shading sign: is it exclusive of endometriomas?
verfasst von
João Lopes Dias
Filipe Veloso Gomes
Rita Lucas
Teresa Margarida Cunha
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0465-1

Weitere Artikel der Ausgabe 7/2015

Abdominal Radiology 7/2015 Zur Ausgabe

Classics in Abdominal Imaging

The “staghorn” calculus

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.